Glucagon-like peptide-1 (GLP-1) -- a therapeutic developed to assist with diabetes -- has also increasingly been prescribed to help patients lose weight
Every factual claim in this ranking links to a public App Store or Google Play listing, with ratings recorded as of June 11, 2026
Actions and interactions of IGF-I and MMPs during muscle regeneration
Unlike systemic IGF-1 LR3, native mechano growth factor has an extremely short half-life, often described in minutes rather than hours, because it is meant to act at the site of damage and then degrade quickly before it can diffuse into general circulation
As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries (97)
talk with a licensed clinician about treatment decisions